Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2005-04-29 | Dr. Merigan, age 71, became Scientific Advisor and a director of Hollis-Eden in March 1996. |
| 2007-04-27 | Dr. Merigan, age 73, became a scientific advisor and director of Hollis-Eden in March 1996. ... The Nominating and Corporate Governance Committee (Nominating Committee) is composed of three directors who are independent ... During 2006, the Nominating Committee consisted of: Messrs. Zizza, Hauer and McDonnell and held one meeting. ... The following table shows for the fiscal year ended December 31, 2006 certain information with respect to the compensation of all non-employee directors of the Company: Thomas C. Merigan ... Total: $75,419. |
| 2008-04-25 | Thomas C. Merigan, Jr., M.D. Dr. Merigan, age 74, became a scientific advisor and director of Hollis-Eden in March 1996. Dr. Merigan was George E. and Lucy Becker Professor of Medicine at Stanford University School of Medicine from 1980 to 2004. ... In September 2007, Dr. Merigan was granted an additional stock option to purchase up to 75,000 shares of our common stock, at an exercise price of $2.14 per share, under the 2005 Directors' Plan. ... The following table shows for the fiscal year ended December 31, 2007 certain information with respect to the compensation of all non-employee directors of the Company: Thomas C. Merigan $20,000 fees earned in cash, $193,282 option awards, total $213,282. |
Data sourced from SEC filings. Last updated: 2026-02-03